Abstract
Background: Neonatal hypoglycemia (NH) is a common disorder affecting 5 to 15% of otherwise healthy infants, such as late preterm, small or large for gestational age, or born to mothers with diabetes. Early management of NH in these at-risk infants is often achieved with administration of formula and/or intravenous (IV) dextrose, which may potentially impair normal metabolic adaptation. Multiple studies have demonstrated that early infant skin-to-skin contact with …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
